Abstract
Currently cardiac biomarkers such as B-type natriuretic peptide (BNP) and N-terminal peptide (NT-proBNP) were widely used to diagnose HF in dyspnoea patients. NT-proBNP is not only also useful for the diagnosis of uncertain dyspnoea patients, but it also plays a crucial role to determine the short-term prognosis of heart failure patients This present study is to assess the role of NT-proBNP as a predicting factor for mortality inpatient admitted with Acute Heart Failure.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
